EMD-32078
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
EMD-32078
Single-particle3.03 Å
Deposition: 18/10/2021Map released: 20/07/2022
Last modified: 23/10/2024
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Vicugna pacos
Sample: SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
Fitted models: 7vq0
Deposition Authors: Maeda R
,
Fujita J
Sample: SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
Fitted models: 7vq0
Deposition Authors: Maeda R
,
Fujita J
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron.
Maeda R ,
Fujita J ,
Konishi Y ,
Kazuma Y ,
Yamazaki H ,
Anzai I ,
Watanabe T,
Yamaguchi K ,
Kasai K ,
Nagata K,
Yamaoka Y ,
Miyakawa K ,
Ryo A ,
Shirakawa K,
Sato K ,
Makino F ,
Matsuura Y ,
Inoue T,
Imura A ,
Namba K ,
Takaori-Kondo A
(2022) Commun Biol , 5 , 669 - 669
,
Fujita J ,
Konishi Y ,
Kazuma Y ,
Yamazaki H ,
Anzai I ,
Watanabe T,
Yamaguchi K ,
Kasai K ,
Nagata K,
Yamaoka Y ,
Miyakawa K ,
Ryo A ,
Shirakawa K,
Sato K ,
Makino F ,
Matsuura Y ,
Inoue T,
Imura A ,
Namba K ,
Takaori-Kondo A
(2022) Commun Biol , 5 , 669 - 669
Grant Support:
- Japan Agency for Medical Research and Development (AMED): JP20fk0108268 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP20fk018517 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP20fk018413 (Japan)
- Japan Society for the Promotion of Science (JSPS): JP20K22630 (Japan)
- Japan Society for the Promotion of Science (JSPS): JP25000013 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP21am0101117 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP17pc0101020 (Japan)
- Japan Science and Technology: JPMJOP1861 (Japan)